NantHealth shares soar 36% in market debut

Shares of NantHealth Inc.
NH, +4.80%
were up 36% in the biotech company's market debut on the Nasdaq Thursday. Shares were trading around $19 in midday trade, above the company's $14 issue price. The company sold 6.5 million shares to raise $91 million. Jefferies LLC and Cowen and Company, LLC acted as the lead underwriters.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information. Intraday data
delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Dow Jones & Company, Inc.
All quotes are in local exchange time. Real time last sale data provided by NASDAQ. More
information on NASDAQ traded symbols and their current financial status. Intraday
data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. S&P/Dow Jones Indices (SM)
from Dow Jones & Company, Inc. SEHK intraday data is provided by SIX Financial Information and is
at least 60-minutes delayed. All quotes are in local exchange time.